Tag: blueleaf
InterVene’s BlueLeaf endovenous valve formation system granted FDA Breakthrough Device designation
InterVene recently announced that it has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the company’s BlueLeaf endovenous valve...
“The future is very bright for venous valve replacement”
The progress of two “promising” new devices in the venous valve replacement space were outlined during a special session at the Society for Vascular...
InterVene Raises $15 Million in Series B funding for catheter-based deep...
InterVene has announced it has raised US$15 million in a Series B financing round. The company’s BlueLeaf Endovenous Valve Formation System is the first catheter-based solution...